Clinical Study

A Randomized Phase III Trial Evaluating The Role Of Axillary Lymph Node Dissection In Breast Cancer Patients (Ct1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

Posted Date: Jun 6, 2018

  • Investigator: Elizabeth Shaughnessy
  • Specialties: Hematology/Oncology, Oncology, Cancer, Radiation Oncology, Surgical Oncology
  • Type of Study: Drug

The purpose of this study is to examine whether removing some of the lymph nodes from the arm pit, but not removing them all followed with radiation therapy (experimental) will be as good as having the majority of the lymph nodes from the arm pit removed during breast surgery followed with radiation (standard of care).

Criteria:

To Qualify You Must Have Breast Cancer That Has Spread To The Lymph Nodes Under Your Arm (In The Arm Pit) And You Have Been Treated With Chemotherapy Before Having Surgery To Remove Any Remaining Breast Cancer.

Keywords:

A011202, Axillary Lymph Node Dissection, Positive Sentinel Lymph Node Disease, Breast, Cancer

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.